StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.80−0.00 (-0.11%)

Close on Nov 20, 2026Market cap $51.45MP/E –Yield –

iBio free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

iBio's free cash flow for the twelve months ending Sep 30, 2026 was -$27.59M. For fiscal 2026 it was -$23.80M. The highest annual figure on record is -$4.12M in fiscal 2014.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$23.80M–
FY2025Jun 30, 2025-$15.32M–
FY2024Jun 30, 2024-$18.76M–
FY2023Jun 30, 2023-$36.17M–
FY2022Jun 30, 2022-$44.81M–
FY2021Jun 30, 2021-$34.98M–
FY2020Jun 30, 2020-$14.42M–
FY2019Jun 30, 2019-$14.90M–
FY2018Jun 30, 2018-$14.41M–
FY2017Jun 30, 2017-$14.49M–
FY2016Jun 30, 2016-$8.14M–
FY2015Jun 30, 2015-$4.74M–
FY2014Jun 30, 2014-$4.12M–
FY2013Jun 30, 2013-$4.86M–
FY2012Jun 30, 2012-$6.01M–
FY2011Jun 30, 2011-$5.34M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026-$9.49M–
Q4 FY2026CQ2 2026Jun 30, 2026-$6.25M–
Q3 FY2026CQ1 2026Mar 31, 2026-$6.10M–
Q2 FY2026CQ4 2025Dec 31, 2025-$5.76M–
Q1 FY2026CQ3 2025Sep 30, 2025-$5.70M–
Q4 FY2025CQ2 2025Jun 30, 2025-$4.62M–
Q3 FY2025CQ1 2025Mar 31, 2025-$3.12M–
Q2 FY2025CQ4 2024Dec 31, 2024-$3.87M–
Q1 FY2025CQ3 2024Sep 30, 2024-$3.72M–
Q4 FY2024CQ2 2024Jun 30, 2024-$5.06M–
Q3 FY2024CQ1 2024Mar 31, 2024-$3.65M–
Q4 FY2023CQ2 2023Jun 30, 2023-$5.48M–
Q3 FY2023CQ1 2023Mar 31, 2023-$3.67M–
Q2 FY2023CQ4 2022Dec 31, 2022-$10.59M–
Q1 FY2023CQ3 2022Sep 30, 2022-$16.44M–
Q4 FY2022CQ2 2022Jun 30, 2022-$14.93M–
Q3 FY2022CQ1 2022Mar 31, 2022-$6.59M–
Q4 FY2021CQ2 2021Jun 30, 2021-$9.74M–
Q3 FY2021CQ1 2021Mar 31, 2021-$8.34M–
Q2 FY2021CQ4 2020Dec 31, 2020-$9.41M–
Q1 FY2021CQ3 2020Sep 30, 2020-$7.49M–
Q4 FY2020CQ2 2020Jun 30, 2020-$4.67M–
Q3 FY2020CQ1 2020Mar 31, 2020-$3.86M–
Q2 FY2020CQ4 2019Dec 31, 2019-$3.61M–
Q1 FY2020CQ3 2019Sep 30, 2019-$2.29M–
Q4 FY2019CQ2 2019Jun 30, 2019-$4.54M–
Q3 FY2019CQ1 2019Mar 31, 2019-$4.26M–
Q2 FY2019CQ4 2018Dec 31, 2018-$5.04M–
Q1 FY2019CQ3 2018Sep 30, 2018-$1.05M–
Q4 FY2018CQ2 2018Jun 30, 2018-$3.60M–
Q3 FY2018CQ1 2018Mar 31, 2018-$3.94M–
Q2 FY2018CQ4 2017Dec 31, 2017-$3.77M–
Q1 FY2018CQ3 2017Sep 30, 2017-$3.11M–
Q4 FY2017CQ2 2017Jun 30, 2017-$4.28M–
Q3 FY2017CQ1 2017Mar 31, 2017-$3.83M–
Q2 FY2017CQ4 2016Dec 31, 2016-$3.70M–
Q1 FY2017CQ3 2016Sep 30, 2016-$2.67M–

More iBio figures

See a number that looks wrong?